Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío
  • Esperanza-Cebollada, Elena
  • Llop, Marta
  • Robledo, Cristina
  • Vicente-Garcés, Clara
  • Alonso, Javier
  • Barragan, Eva
  • Fernández, Guerau
  • Hernández-Sánchez, Jesús M
  • Martín-Izquierdo, Marta
  • Maynou, Joan
  • Minguela, Alfredo
  • Montaño, Adrián
  • Ortega, Margarita
  • Torrebadell, Montserrat
  • Cervera, José
  • Sánchez, Joaquín
  • Jiménez-Velasco, Antonio
  • Riesco, Susana
  • Hernández-Rivas, Jesús M
  • Lassaletta, Álvaro
  • Fernández, José María
  • Rives, Susana
  • Dapena, José Luis
  • Ramírez, Manuel
  • Camós, Mireia
  • Spanish Society of Pediatric Hematology and Oncology (SEHOP). Group of Leukemia
The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology's complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (OncomineTM Childhood Cancer Research Assay; Archer®FusionPlex® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Ventricular fibrillation conduction through an isthmus of preserved myocardium between radiofrequency lesions

  • CHORRO GASCO, FCO JAVIER
  • Ibañez Catala, Xavier
  • TRAPERO, ISABEL
  • SUCH-MIQUEL, LUIS M
  • PELECHANO, FRANCISCA
  • CÁNOVES, JOAQUÍN
  • MAINAR LATORRE, LUIS
  • CERDA, JOSE M.
  • ALBEROLA, ANTONIO
  • SUCH, L
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
[EN] Background: Selective local acceleration of myocardial activation during ventricular fibrillation (VF) contributes information on the interactions between neighboring zones during the arrhythmia. This study analyzes these interactions, centering the observations on an isthmus of myocardium between two radiofrequency (RF) lesions. Methods: In nine isolated rabbit hearts, a gap of preserved myocardium was established between two RF lesions in the anterolateral left ventricle (LV) wall. Before, during, and after increasing the spatial heterogeneity of VF by local myocardial stretching, VF epicardial recordings were obtained. Results: Local stretch in the anterior LV wall decreased the excitable window (17 ±7ms vs 26 ±7ms; P < 0.05) and increased the dominant frequency (DFr; 18.9 ± 5.0 Hz vs 15.2 ± 3.6 Hz; P < 0.05) in this zone, without changes in the non-stretched posterolateral zone (25 ±4ms vs 27 ± 6 ms, ns and 14.1 ± 2.7 Hz vs 14.3 ± 3.0 Hz, ns). The DFr ratio at both sides of the gap was inversely correlated to the excitable window ratio (R = ¿0.57; P = 0.002). Before (31% vs 26%), during (29% vs 22%), and after stretch suppression (35% vs 25%), the wavefronts passing through the gap from the posterolateral to the anterior LV wall were seen to predominate. The number of wavefronts that passed from the anterior to the posterolateral LV wall was related to the excitable window in this zone (R = 0.41; P = 0.03). Conclusions: The VF acceleration induced in the stretched zone does not increase the flow of wavefronts toward the non-stretched zone in the adjacent gap of preserved myocardium. The absence of significant changes in the electrophysiological parameters of the non-stretched myocardium limits the arrival of wavefronts in this zone. (PACE 2013; 36:286¿298), Grants: This work was supported by Spanish Ministry of Science "Instituto de Salud Carlos III" Grants FIS PS09/02417 and RETIC REDINSCOR RD06/0003/0010, and by "Generalitat Valenciana" Grant PROMETEO 2010/093.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Modifications in Ventricular Fibrillation and Capture Capacity Induced by a Linear Radiofrequency Lesion, Modificaciones de la fibrilación ventricular y de la capacidad de captura inducidas por una lesión lineal con radiofrecuencia

  • Chorro, Francisco J.
  • Pelechano Ribes, Francisca
  • Trapero, Isabel
  • Ibañez Catala, Xavier
  • Such-Miquel, Luis
  • Guerrero, Juan
  • Canoves, Joaquin
  • Mainar, Luis
  • Alberola, Antonio
  • Such, Luis
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
  • Millet Roig, José|||0000-0002-8879-003X
[EN] Introduction and objectives: An analysis was made of the effects of a radiofrequency-induced linear lesion during ventricular fibrillation and the capacity to capture myocardium through high-frequency pacing. Methods: Using multiple epicardial electrodes, ventricular fibrillation was recorded in 22 isolated perfused rabbit hearts, analyzing the activation maps upon applying trains of stimuli at 3 different frequencies close to that of the arrhythmia: a) at baseline; b) after radio-frequency ablation to induce a lesion of the left ventricular free wall (length=10 [1] mm), and c) after lengthening the lesion (length=23 [2] mm). Results: Following lesion induction, the regularity of the recorded signals decreased and significant variations in the direction of the activation fronts were observed. On lengthening the lesion, there was a slight increase in the episodes with at least 3 consecutive captures when pacing at cycles 10% longer than the arrhythmia (baseline: 0.6 [0.7]; initial lesion: 1 [1] no significant differences; lengthened lesion: 3 [2.8]; P<.001), while a decrease was observed in those obtained upon pacing at cycles 10% shorter than the arrhythmia. Conclusions: The radio-frequency -induced lesion increases the heterogeneity of myocardial activation during ventricular fibrillation and modifies arrival of the activation fronts in the adjacent zones. High-frequency pacing during ventricular fibrillation produces occasional captures during at least 3 consecutive stimuli. The lengthened lesion in turn slightly increases capture capacity when using cycles slightly longer than the arrhythmia. (C) 2011 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L. All rights reserved., [ES] Introducción y objetivos Analizar los efectos, en la fibrilación ventricular y en la capacidad de capturar al miocardio mediante estimulación a frecuencias rápidas, de una lesión lineal producida con radiofrecuencia. Métodos En 22 corazones de conejo aislados y perfundidos, se utilizaron electrodos múltiples epicárdicos para registrar la fibrilación ventricular. Se analizaron los mapas de activación al aplicar trenes de estímulos a tres frecuencias distintas, cercanas a las de la arritmia, en tres situaciones: a) basalmente, b) tras producir con radiofrecuencia una lesión en la pared libre del ventrículo izquierdo (longitud, 10 ± 1 mm), y c) tras ampliar su extensión (longitud, 23 ± 2 mm). Resultados Tras la lesión, se observó una disminución de la regularidad de las señales registradas y variaciones significativas en la dirección de los frentes de activación. Con la lesión ampliada, se incrementaron ligeramente los episodios con al menos tres capturas consecutivas al estimular con ciclos un 10% más largos que los de la arritmia (basal, 0,6 ± 0,7; lesión inicial, 1 ± 1, diferencias no significativas; lesión ampliada, 3 ± 2,8; p < 0,001), mientras que se redujeron los obtenidos al estimular con ciclos un 10% más cortos que los de la arritmia. Conclusiones La lesión efectuada con radiofrecuencia aumenta la heterogeneidad de la activación miocárdica durante la fibrilación ventricular y modifica la llegada de los frentes de activación a las zonas adyacentes. La estimulación durante la fibrilación ventricular a frecuencias rápidas provoca capturas ocasionales durante al menos tres estímulos consecutivos. La lesión ampliada incrementa ligeramente la capacidad de captura al utilizar ciclos ligeramente más largos que los de la fibrilación ventricular., This study was funded by research grants from the Instituto de Salud Carlos III FIS PI06/0758-PS09/02417 and RETIC REDINSCOR RD06/0003/0010, from the Generalitat Valenciana PROMETEO 2010/093, and from the Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Experimental Study of the Effects of EIPA, Losartan, and BQ-123 on Electrophysiological Changes Induced by Myocardial Stretch, Estudio experimental de los efectos de EIPA, losartán y BQ-123 sobre las modificaciones electrofisiológicas inducidas por el estiramiento miocárdico

  • Chorro, Francisco J.
  • Canto Serrano, Irene Del
  • Brines, Laia
  • Such-Miquel, Luis
  • Soler, Carlos
  • Zarzoso, Manuel
  • Trapero, Isabel
  • Such, Luis
  • Calvo Saiz, Conrado Javier
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
[ES] Introducción y objetivos Se han implicado diversos mecanismos en la respuesta mecánica al estiramiento miocárdico, que incluyen la activación del intercambiador Na+/H+ por acciones autocrinas y paracrinas. Se estudia la participación de estos mecanismos en las respuestas electrofisiológicas al estiramiento agudo miocárdico mediante el análisis de los cambios inducidos con fármacos. Métodos Se analizan las modificaciones de la fibrilación ventricular inducidas por el estiramiento agudo miocárdico en corazones de conejo aislados y perfundidos utilizando electrodos múltiples epicárdicos y técnicas cartográficas. Se estudian 4 series: control (n = 9); durante la perfusión del antagonista de los receptores de la angiotensina II, losartán (1 ¿M, n = 8); durante la perfusión del bloqueador del receptor de la endotelina A, BQ-123 (0,1 ¿M, n = 9), y durante la perfusión del inhibidor del intercambiador Na+/H+, EIPA (5-[N-ethyl-N-isopropyl]-amiloride) (1 ¿M, n = 9). Resultados EIPA atenuó el aumento de la frecuencia dominante de la fibrilación producido por el estiramiento (control = 40,4%; losartán = 36% [no significativo]; BQ-123 = 46% [no significativo], y EIPA = 22% [p < 0,001]). Durante el estiramiento, la complejidad de los mapas de activación fue menor en la serie con EIPA (p < 0,0001) y también en esta serie fue mayor la concentración espectral de la arritmia (mayor regularidad): control = 18 ± 3%; EIPA = 26 ± 9% (p < 0,02); losartán = 18 ± 5% (no significativo), y BQ-123 = 18 ± 4% (no significativo). Conclusiones El inhibidor del intercambiador Na+/H+ EIPA atenúa los efectos electrofisiológicos responsables de la aceleración y del aumento de la complejidad de la fibrilación ventricular producidos por el estiramiento agudo miocárdico. Por el contrario, el antagonista de los receptores de la angiotensina II, losartán, y el del receptor A de la endotelina, BQ-123, no modifican estos efectos., [EN] Introduction and objectives Mechanical response to myocardial stretch has been explained by various mechanisms, which include Na+/H+ exchanger activation by autocrine-paracrine system activity. Drug-induced changes were analyzed to investigate the role of these mechanisms in the electrophysiological responses to acute myocardial stretch. Methods Multiple epicardial electrodes and mapping techniques were used to analyze changes in ventricular fibrillation induced by acute myocardial stretch in isolated perfused rabbit hearts. Four series were studied: control (n = 9); during perfusion with the angiotensin receptor blocker losartan (1 ¿M, n = 8); during perfusion with the endothelin A receptor blocker BQ-123 (0.1 ¿M, n = 9), and during perfusion with the Na+/H+ exchanger inhibitor EIPA (5-[N-ethyl-N-isopropyl]-amiloride) (1 ¿M, n = 9). Results EIPA attenuated the increase in the dominant frequency of stretch-induced fibrillation (control = 40.4%; losartan = 36% [not significant]; BQ-123 = 46% [not significant]; and EIPA = 22% [P < .001]). During stretch, the activation maps were less complex (P < .0001) and the spectral concentration of the arrhythmia was greater (greater regularity) in the EIPA series: control = 18 (3%); EIPA = 26 (9%) (P < .02); losartan = 18 (5%) (not significant); and BQ-123 = 18 (4%) (not significant). Conclusions The Na+/H+ exchanger inhibitor EIPA attenuated the electrophysiological effects responsible for the acceleration and increased complexity of ventricular fibrillation induced by acute myocardial stretch. The angiotensin II receptor antagonist losartan and the endothelin A receptor blocker BQ-123 did not modify these effects., This study was funded by the Spanish Department of Science (Instituto de Salud Carlos III): projects FIS PS09/02417, FIS PI12/00407, and RETIC "RIC" RD12/0042/0048, and Generalitat Valenciana: project PROMETEO 2010/093
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

  • Vega-García, Nerea
  • Perez-Jaume, Sara
  • Esperanza-Cebollada, Elena|||0000-0001-5451-0370
  • Vicente-Garcés, Clara|||0000-0002-2556-043X
  • Torrebadell, Montserrat
  • Jiménez-Velasco, Antonio|||0000-0001-6421-7872
  • Ortega-Blanco, Margarita
  • Llop, Marta
  • Abad, Lorea
  • Vagace Valero, José Manuel|||0000-0001-8751-4319
  • Minguela, Alfredo|||0000-0003-2472-5893
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Sánchez-Garcia, Joaquin
  • García-Calderón, Clara B.
  • Gómez-Casares, María Teresa
  • Martín-Clavero, Estela
  • Escudero, Adela
  • Riñón Martinez-Gallo, Marta
  • Muñoz, Luz
  • Velasco, María Rosario
  • García-Morin, Marina|||0000-0003-1405-2912
  • Català, Albert|||0000-0003-0133-1752
  • Pascual, Antonia
  • Velasco Puyo, Pablo|||0000-0001-7331-9483
  • Fernández, José María
  • Lassaletta, Álvaro|||0000-0003-2881-1473
  • Fuster, José Luis|||0000-0002-4881-9440
  • Badell Serra, Isabel|||0000-0001-6546-2175
  • Molinos-Quintana, Águeda
  • Molinés, Antonio
  • Guerra-García, Pilar
  • Pérez Martínez, Antonio|||0000-0002-6436-9195
  • García-Abós, Miriam
  • Robles Ortiz, Reyes
  • Pisa Gatell, Sandra
  • Adán, Rosa
  • Díaz de Heredia, Cristina|||0000-0001-8086-296X
  • Dapena, José Luis|||0000-0002-6711-7479
  • Rives, Susana|||0000-0002-5658-1831
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Camós, Mireia|||0000-0003-3658-7942
Robust and applicable risk-stratifying genetic factors at diagnosis in pediatric T-cell acute lymphoblastic leukemia (T-ALL) are still lacking, and most protocols rely on measurable residual disease (MRD) assessment. In our study, we aimed to analyze the impact of NOTCH1, FBXW7, PTEN, and RAS mutations, the measurable residual disease (MRD) levels assessed by flow cytometry (FCM-MRD) and other reported risk factors in a Spanish cohort of pediatric T-ALL patients. We included 199 patients treated with SEHOP and PETHEMA consecutive protocols from 1998 to 2019. We observed a better outcome of patients included in the newest SEHOP-PETHEMA-2013 protocol compared to the previous SHOP-2005 cohort. FCM-MRD significantly predicted outcome in both protocols, but the impact at early and late time points differed between protocols. The impact of FCM-MRD at late time points was more evident in SEHOP-PETHEMA 2013, whereas in SHOP-2005 FCM-MRD was predictive of outcome at early time points. Genetics impact was different in SHOP-2005 and SEHOP-PETHEMA-2013 cohorts: NOTCH1 mutations impacted on overall survival only in the SEHOP-PETHEMA-2013 cohort, whereas homozygous deletions of CDKN2A/B had a significantly higher CIR in SHOP-2005 patients. We applied the clinical classification combining oncogenetics, WBC count and MRD levels at the end of induction as previously reported by the FRALLE group. Using this score, we identified different subgroups of patients with statistically different outcome in both Spanish cohorts. In SHOP-2005, the FRALLE classifier identified a subgroup of high-risk patients with poorer survival. In the newest protocol SEHOP-PETHEMA-2013, a very low-risk group of patients with excellent outcome and no relapses was detected, with borderline significance. Overall, FCM-MRD, WBC count and oncogenetics may refine the risk-stratification, helping to design tailored approaches for pediatric T-ALL patients.